Open access
2026
IMMUNOHISTOCHEMICAL EXPRESSION OF CXCR2 IN BREAST CARCINOMA AND ITS ASSOCIATION WITH ER, PR AND HER2/NEU STATUS: A CROSS-SECTIONAL STUDY FROM A TERTIARY CARE CENTRE
A potential role for CXCR2 as a biomarker of tumor aggressiveness and a candidate prognostic stem-cell related marker in breast carcinoma is supported and larger multicentric studies with survival analysis and molecular validation are required to confirm its clinical utility.
A. Shaikh, Nishi Tandon, Zareen Fatima et al.
· Asian Journal of Medical Res... · 0 citations